These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21455071)

  • 1. New molecules for the treatment of pain.
    Heinzmann S; McMahon SB
    Curr Opin Support Palliat Care; 2011 Jun; 5(2):111-5. PubMed ID: 21455071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor and Molecular Targets for the Development of Novel Opioid and Non-Opioid Analgesic Therapies.
    Chen R; Coppes OJM; Urman RD
    Pain Physician; 2021 Mar; 24(2):153-163. PubMed ID: 33740349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of new analgesics.
    Lötsch J; Geisslinger G
    Br J Pharmacol; 2011 Jun; 163(3):447-60. PubMed ID: 20942817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Future pain treatment].
    Rygh LJ; Fagerlund TH; Svendsen F
    Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1917-22. PubMed ID: 11488183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical toxicity evaluation of AAV for pain: evidence from human AAV studies and from the pharmacology of analgesic drugs.
    Pleticha J; Heilmann LF; Evans CH; Asokan A; Samulski RJ; Beutler AS
    Mol Pain; 2014 Sep; 10():54. PubMed ID: 25183392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future potential and status of selective sodium channel blockers for the treatment of pain.
    Priest BT
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):682-92. PubMed ID: 19736626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variability of pain perception and treatment--clinical pharmacological implications.
    Lötsch J
    Eur J Clin Pharmacol; 2011 Jun; 67(6):541-51. PubMed ID: 21344316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsaicin: Current Understanding of Its Mechanisms and Therapy of Pain and Other Pre-Clinical and Clinical Uses.
    Fattori V; Hohmann MS; Rossaneis AC; Pinho-Ribeiro FA; Verri WA
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27367653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathophysiology of pain.
    Garrett N; McShane F
    AANA J; 1999 Aug; 67(4):349-57. PubMed ID: 10497457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What can chronic arthritis pain teach about developing new analgesic drugs?
    Witter J; Dionne RA
    Arthritis Res Ther; 2004; 6(6):279-81. PubMed ID: 15535840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain, analgesia and genetics.
    Muralidharan A; Smith MT
    J Pharm Pharmacol; 2011 Nov; 63(11):1387-400. PubMed ID: 21988420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of pathophysiology and treatment of neuropathic pain.
    Vranken JH
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacogenetics of analgesia.
    Stamer UM; Stüber F
    Expert Opin Pharmacother; 2007 Oct; 8(14):2235-45. PubMed ID: 17927480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacogenetics of analgesia: toward a genetically-based approach to pain management.
    Flores CM; Mogil JS
    Pharmacogenomics; 2001 Aug; 2(3):177-94. PubMed ID: 11535108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
    García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
    J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Na
    Yang Y; Mis MA; Estacion M; Dib-Hajj SD; Waxman SG
    Trends Pharmacol Sci; 2018 Mar; 39(3):258-275. PubMed ID: 29370938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient receptor potential channels - emerging novel drug targets for the treatment of pain.
    Sałat K; Moniczewski A; Librowski T
    Curr Med Chem; 2013; 20(11):1409-36. PubMed ID: 23409716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New aspects in pain research at Bayer].
    Nopper R; Gebert I
    Fortschr Neurol Psychiatr; 2003 Dec; 71(12):683-9. PubMed ID: 14661162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lost but making progress--Where will new analgesic drugs come from?
    Borsook D; Hargreaves R; Bountra C; Porreca F
    Sci Transl Med; 2014 Aug; 6(249):249sr3. PubMed ID: 25122640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No gain, no pain: NaV1.7 as an analgesic target.
    King GF; Vetter I
    ACS Chem Neurosci; 2014 Sep; 5(9):749-51. PubMed ID: 25111714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.